Although cancer of the prostate (CaP) is the most commonly occurring cancer in males,
there are major limitations in its diagnosis and long-term cure. Consequently, understanding …

Methods Twenty healthy volunteers with skin types I to III participated (age range, 20-45
years; median, 24 years). Exclusion criteria were exposure tosun or solarium during the past …

Without steroid 5α-reductase (5AR) I and II mRNA in Gleason 4, 5 prostate cancer there is
no 5AR I and II in such disease [1]. Genetic and epigenetic factors lower 5AR and are …

1. Hurst EA, Harbour JW, Cornelius LA. Ocular melanoma: a review and the relationship to
cutaneous melanoma. Arch Dermatol. 2003; 139: 1067-1073. 2. Shors AR, Iwamoto S …

In an article in the August 10th issue, NCI Director Andrew von Eschenbach, MD, when
asked if the Prostate Cancer Prevention Trial (PCPT) had sent some mixed cancer …

On Sept. 26, 1998, a quarter of a million people rallied in Washington, DC, joined by sev-
eral hundred thousand others throughout the country to roar out a call for quality cancer care …

We read with interest this article [1] outlining the role that urinary markers have as adjuncts
to cystoscopy and urine cytology. However, this review failed to mention the increasing role …

Re: Long-term effects of finasteride on prostate specific antigen levels: results from the
Prostate Cancer Prevention Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF
TUMOR REGRESSION IN PROSTATE CANCER | Journal of Urology AUA Journals The Journal …